|
|
||||||||
Université de Caen, CNRS UMR 6551, IFR 47, bd H. Becquerel, BP 5229, 14074 Caen Cedex, France; and
* Max-Planck-Institut, für physiologische und klinische Forschung, D-61231 Bad-Nauheim, Germany
1Correspondence: Université de CAEN-CNRS UMR 6551, Laboratoire de Neurosciences, BP 5229, 14074 Caen Cedex, France. E-mail: d.vivien{at}neuro.unicaen.fr
The tissue type plasminogen activator (t-PA) is a serine protease that is involved in neuronal plasticity and cell death induced by excitotoxins and ischemia in the brain. t-PA activity in the central nervous system is regulated through the activation of serine protease inhibitors (serpins) such as the plasminogen activator inhibitor (PAI-1), the protease nexin-1 (PN-1), and neuroserpin (NSP). Recently we demonstrated in vitro that PAI-1 produced by astrocytes mediates the neuroprotective effect of the transforming growth factor-ß1 (TGF-ß1) in NMDA-induced neuronal cell death. To investigate whether serpins may be involved in neuronal cell death after cerebral ischemia, we determined, by using semiquantitative RT-PCR and in situ hybridization, that focal cerebral ischemia in mice induced a dramatic overexpression of PAI-1 without any effect on PN-1, NSP, or t-PA. Then we showed that although the expression of PAI-1 is restricted to astrocytes, PN-1, NSP, and t-PA are expressed in both neurons and astrocytes. Moreover, by using semiquantitative RT-PCR and Western blotting, we observed that only the expression of PAI-1 was modulated by TGF-ß1 treatment via a TGF-ß-inducible element contained in the PAI-1 promoter (CAGA box). Finally, we compared the specificity of TGF-ß1 action with other members of the TGF-ß family by using luciferase reporter genes. These data show that TGF-ß and activin were able to induce the overexpression of PAI-1 in astrocytes, but that bone morphogenetic proteins, glial cell line-derived neutrophic factor, and neurturin did not. These results provide new insights into the regulation of the serpins/t-PA axis and the mechanism by which TGF-ß may be neuroprotective.Docagne, F., Nicole, O., Marti, H. H., MacKenzie, E. T., Buisson, A., Vivien, D. Transforming growth factor-ß1 as a regulator of the serpins/t-PA axis in cerebral ischemia.
Key Words: TGF-ß plasminogen activator neuroserpin NTN
This article has been cited by other articles:
![]() |
K. Yoshinaga, K. Yamashita, K. Mimori, F. Tanaka, H. Inoue, and M. Mori Activin A Causes Cancer Cell Aggressiveness in Esophageal Squamous Cell Carcinoma Cells Ann. Surg. Oncol., January 1, 2008; 15(1): 96 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Lelong, I. Bieche, E. Perez, K. Bigot, J. Leemput, I. Laurendeau, M. Vidaud, J.-P. Jais, M. Menasche, and M. Abitbol Novel Mouse Model of Monocular Amaurosis Fugax Stroke, December 1, 2007; 38(12): 3237 - 3244. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fredriksson, M. Ehnman, C. Fieber, and U. Eriksson Structural Requirements for Activation of Latent Platelet-derived Growth Factor CC by Tissue Plasminogen Activator J. Biol. Chem., July 22, 2005; 280(29): 26856 - 26862. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lesne, F. Docagne, C. Gabriel, G. Liot, D. K. Lahiri, L. Buee, L. Plawinski, A. Delacourte, E. T. MacKenzie, A. Buisson, et al. Transforming Growth Factor-beta 1 Potentiates Amyloid-beta Generation in Astrocytes and in Transgenic Mice J. Biol. Chem., May 9, 2003; 278(20): 18408 - 18418. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hosomi, J. Lucero, J. H. Heo, J. A. Koziol, B. R. Copeland, and G. J. del Zoppo Rapid Differential Endogenous Plasminogen Activator Expression After Acute Middle Cerebral Artery Occlusion Stroke, June 1, 2001; 32(6): 1341 - 1348. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |